Traumatic Brain Injury – National Society of Regenerative Medicine

Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer’s Disease

Alzheimer’s disease (AD), a progressive neurodegenerative disorder featuring memory loss and cognitive impairment, is caused by synaptic failure and the excessive accumulation of misfolded proteins. Many unsuccessful attempts have been made to develop new small molecules or antibodies to intervene in the disease’s pathogenesis. [pdf-embedder url="https://www.nsorm.com/wp-content/uploads/2018/07/Stem-Cells-in-Alzheimers-Dis-Mar-2018.pdf" title="Stem Cells in Alzheimer's Dis Mar 2018"]

Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury

Annually, around 10 million people worldwide suffer traumatic brain injuries (TBIs), which lead either to death or hospitalization. In the USA alone, an estimated 1.7 million people sustain a TBI each year, with death being the outcome for about 52,000 of those affected. [pdf-embedder url="https://www.nsorm.com/wp-content/uploads/2018/07/MSCs-in-the-TX-of-Traumatic-Brain-Injury-Feb-2017.pdf" title="MSC's in the TX of Traumatic Brain Injury Feb 2017"]